Suchergebnisse - "Martinez, Felipe A"

PubPharm (7)

1

Dapagliflozin and Timing of Prior Heart Failure Hospitalization : A Patient-Level Meta-Analysis of DAPA-HF and DELIVER

enthalten in: JACC. Heart failure | 2024

von Butt, J. | Jhund, P. | Docherty, K. | +15

2

Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin : A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER

enthalten in: Journal of cardiac failure | 2024

von Butt, J. | Jering, K. | DE Boer, R. | +20

3

Efficacy of Dapagliflozin According to Heart Rate : A Patient-Level Pooled Analysis of DAPA-HF and DELIVER

enthalten in: Circulation. Heart failure | 2023

von Kondo, T. | Butt, J. | Curtain, J. | +17

4

Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure

enthalten in: Journal of the American College of Cardiology | 2023

von Kondo, T. | Wang, X. | Yang, M. | +19

5

Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction Spectrum

enthalten in: JACC. Heart failure | 2023

von Butt, J. | Docherty, K. | Claggett, B. | +22

CommentIn: JACC Heart Fail. 2023 Apr;11(4):389-391. - PMID 36892487

6

Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure : A Prespecified Analysis of the DELIVER Trial

enthalten in: Circulation | 2023

von Kondo, T. | Jering, K. | Borleffs, C. | +17

7

Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score : Insights From DAPA-HF

enthalten in: JACC. Heart failure | 2022

von Butt, J. | Dewan, P. | DeFilippis, E. | +15

CommentIn: JACC Heart Fail. 2022 Aug;10(8):556-558. - PMID 35902158

1
[1]